Finch Therapeutics Group, Inc. Contracts & Agreements
32 Contracts & Agreements
- Business Finance (7 contracts)
- Human Resources (10)
- Intellectual Property (4)
- Real Estate (4)
- Uncategorized (7)
- 2017 Equity Incentive Plan, as amended, and the forms of agreements thereunder (Filed With SEC on August 10, 2023)
- 2021 Equity Incentive Plan, as amended, and the forms of agreements thereunder (Filed With SEC on August 10, 2023)
- 2021 Employee Stock Purchase Plan, as amended (Filed With SEC on August 10, 2023)
- Lease Termination Agreement, dated as of May 12, 2023, by and between the Company and NRL WCS 200 Inner Belt Prop, LLC (Filed With SEC on May 18, 2023)
- Amendment No. 3, dated October 19, 2022, to the Amended and Restated Agreement by and between Finch Therapeutics, Inc. and Millennium Pharmaceuticals, Inc., dated as of October... (Filed With SEC on November 10, 2022)
- Loan and Security Agreement, dated May 11, 2022, by and among Finch Therapeutics Group, Inc. and each of its Subsidiaries, the several banks and other financial institutions or... (Filed With SEC on May 16, 2022)
- Description of Registrants Securities (Filed With SEC on March 31, 2022)
- Amended and Restated Exclusive License Agreement between Regents of the University of Minnesota and Finch Therapeutics Holdings LLC, dated January 28, 2022 (Filed With SEC on March 31, 2022)
- Amendment No. 2, dated November 12, 2021, to the Amended and Restated Agreement by and between Finch Therapeutics, Inc. and Millennium Pharmaceuticals, Inc. dated as of October... (Filed With SEC on March 31, 2022)
- Release Agreement, dated November 4, 2021, by and between Finch Therapeutics Group, Inc. and Zain Kassam (Filed With SEC on March 31, 2022)
- Executive Employment Agreement by and between Finch Therapeutics Group, Inc. and Marc Blaustein, dated as of September 8, 2021 (Filed With SEC on March 31, 2022)
- Amended and Restated Executive Employment Agreement by and between Finch Therapeutics Group, Inc. and Joseph Vittiglio, dated as of March 12, 2021 (Filed With SEC on March 31, 2022)
- Amendment No. 1 to the Amended and Restated Executive Employment Agreement by and between Finch Therapeutics Group, Inc. and Joseph Vittiglio, dated as of March 18, 2021 (Filed With SEC on March 31, 2022)
- Amendment, dated August 9, 2021, to the Amended and Restated Agreement, by and between Finch Therapeutics, Inc. and Millennium Pharmaceuticals, Inc., dated as of October 21, 2019 (Filed With SEC on November 10, 2021)
- Lease, dated August 3, 2021, by and between Hood Park LLC and Finch Therapeutics, Inc (Filed With SEC on November 10, 2021)
- Form of Underwriting Agreement (Filed With SEC on March 15, 2021)
- Form of Common Stock Certificate (Filed With SEC on March 15, 2021)
- Form of Indemnity Agreement between the registrant and its directors and officers (Filed With SEC on March 15, 2021)
- 2021 Equity Incentive Plan and the forms of agreements thereunder (Filed With SEC on March 15, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on March 15, 2021)
- Amended and Restated Executive Employment Agreement by and between the registrant and Mark Smith, dated as of March 12, 2021, to be effective upon the pricing of this offering (Filed With SEC on March 15, 2021)
- Amended and Restated Executive Employment Agreement by and between the registrant and Zain Kassam, dated as of March 12, 2021, to be effective upon the pricing of this offering (Filed With SEC on March 15, 2021)
- Amended and Restated Executive Employment Agreement by and between the registrant and Gregory D. Perry, dated as of March 12, 2021, to be effective upon the pricing of this... (Filed With SEC on March 15, 2021)
- Third Amended and Restated Stockholders Agreement by and among the registrant and certain of its stockholders, dated as of September 2, 2020 (Filed With SEC on February 26, 2021)
- 2017 Equity Incentive Plan, as amended, and the forms of agreements thereunder (Filed With SEC on February 26, 2021)
- Exclusive Patent License Agreement by and between CIPAC Limited and Regents of the University of Minnesota, dated as of March 26, 2012, as amended July 10, 2014, October 23, 2014,... (Filed With SEC on February 26, 2021)
- Exclusive License Agreement by and between Crestovo, LLC and Arizona Science and Technology Enterprises LLC, dated as of July 3, 2017, as amended August 27, 2018 (Filed With SEC on February 26, 2021)
- Amended and Restated Agreement by and between Finch Therapeutics, Inc. and Millennium Pharmaceuticals, Inc., dated as of October 21, 2019 (Filed With SEC on February 26, 2021)
- Asset Purchase Agreement by and between Finch Therapeutics, Inc. and Microbiome Health Research Institute, Inc., dated as of November 19, 2020 (Filed With SEC on February 26, 2021)
- LMIC License Agreement by and between Finch Therapeutics, Inc. and Microbiome Health Research Institute, Inc., dated as of November 19, 2020 (Filed With SEC on February 26, 2021)
- Lease by and between NextBiome, Inc. and North River II LLC, dated as of December 21, 2015 (Filed With SEC on February 26, 2021)
- First Amendment to Lease by and between Finch Therapeutics, Inc. and North River II LLC, dated as of January 20, 2017 (Filed With SEC on February 26, 2021)
